More recently, ACT in the mouse model of experimental HCT and CMV infection has shown that antiviral CD8+ T cells not only prevent viral histopathology in organs but also preclude graft failure (26) from CMV-associated inhibition of the hematopoietic repopulation of bone marrow stroma (27–29). The gene discussed is CD8A; the disease is cytomegalovirus infection.